KRW 16060.0
(-3.37%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 134.89 KRW | -77.07% |
2022 | 588.19 KRW | -37.16% |
2021 | 936.04 KRW | -5.17% |
2020 | 987.07 KRW | 14.57% |
2019 | 861.56 KRW | 4.36% |
2018 | 825.59 KRW | 44.09% |
2017 | 572.96 KRW | -10.5% |
2016 | 640.16 KRW | 18.87% |
2015 | 538.52 KRW | -31.96% |
2014 | 791.50 KRW | 14.88% |
2013 | 689.00 KRW | 91.75% |
2012 | 359.33 KRW | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q3 | 30.76 KRW | 3364.86% |
2024 Q1 | -12.93 KRW | 85.29% |
2024 Q2 | 1.11 KRW | 108.58% |
2023 Q2 | 100.41 KRW | -67.28% |
2023 FY | - KRW | -77.07% |
2023 Q1 | 306.89 KRW | 757.01% |
2023 Q3 | -31.23 KRW | -131.1% |
2023 Q4 | -87.87 KRW | -181.36% |
2022 Q2 | 88.03 KRW | -81.47% |
2022 Q1 | 475.15 KRW | 386.19% |
2022 FY | - KRW | -37.16% |
2022 Q4 | -46.71 KRW | -164.04% |
2022 Q3 | 72.94 KRW | -17.14% |
2021 FY | - KRW | -5.17% |
2021 Q2 | 325.94 KRW | 27.57% |
2021 Q3 | 256.86 KRW | -21.19% |
2021 Q1 | 255.50 KRW | -2.47% |
2021 Q4 | 97.73 KRW | -61.95% |
2020 Q3 | 223.50 KRW | -14.69% |
2020 FY | - KRW | 14.57% |
2020 Q4 | 261.98 KRW | 17.22% |
2020 Q2 | 262.00 KRW | 9.62% |
2020 Q1 | 239.00 KRW | 399.42% |
2019 FY | - KRW | 4.36% |
2019 Q4 | -79.82 KRW | -126.3% |
2019 Q3 | 303.50 KRW | -30.15% |
2019 Q2 | 434.50 KRW | 129.89% |
2019 Q1 | 189.00 KRW | -38.85% |
2018 Q3 | 243.00 KRW | 54.68% |
2018 FY | - KRW | 44.09% |
2018 Q2 | 157.10 KRW | 36.02% |
2018 Q1 | 115.50 KRW | -29.46% |
2018 Q4 | 309.09 KRW | 27.2% |
2017 Q2 | 211.36 KRW | 171.04% |
2017 FY | - KRW | -10.5% |
2017 Q1 | 77.98 KRW | -58.17% |
2017 Q3 | 137.00 KRW | -35.18% |
2017 Q4 | 163.73 KRW | 19.51% |
2016 FY | - KRW | 18.87% |
2016 Q2 | 129.43 KRW | -4.82% |
2016 Q1 | 135.99 KRW | -19.45% |
2016 Q3 | 186.50 KRW | 44.09% |
2016 Q4 | 186.42 KRW | -0.04% |
2015 Q1 | 101.04 KRW | -74.51% |
2015 Q4 | 168.82 KRW | 47.44% |
2015 Q2 | 152.01 KRW | 50.45% |
2015 Q3 | 114.50 KRW | -24.68% |
2015 FY | - KRW | -31.96% |
2014 Q3 | 125.65 KRW | -18.4% |
2014 FY | - KRW | 14.88% |
2014 Q1 | 115.72 KRW | -42.6% |
2014 Q4 | 396.46 KRW | 215.53% |
2014 Q2 | 153.98 KRW | 33.06% |
2013 Q1 | 120.92 KRW | -10.06% |
2013 Q2 | 168.67 KRW | 39.49% |
2013 FY | - KRW | 91.75% |
2013 Q3 | 193.00 KRW | 14.42% |
2013 Q4 | 201.62 KRW | 4.47% |
2012 Q3 | 69.00 KRW | 0.0% |
2012 Q4 | 134.45 KRW | 94.86% |
2012 FY | - KRW | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Osang Healthcare Co.,Ltd | 9148.00 KRW | 98.525% |
InBody Co.,Ltd | 2819.01 KRW | 95.215% |
Curexo Inc. | -120.00 KRW | 212.408% |
Seegene, Inc. | 14.19 KRW | -850.599% |
Ray Co., Ltd. | -140.25 KRW | 196.178% |
Gencurix Inc. | -1629.25 KRW | 108.279% |
Sugentech Inc. | -1090.00 KRW | 112.375% |
L&C Bio Co., Ltd | 2096.33 KRW | 93.565% |